Podcasts about eeg

In this episode Dr. Simon Ruffell joins to discuss the research on ayahuasca for PTSD. Dr. Ruffell is a psychiatrist, researcher, and student of curanderismo (Amazonian shamanism) working at the intersection of Western psychiatry, traditional plant medicine, and Indigenous knowledge systems. He is Executive Director of Onaya, Lecturer in Psychology and Psychedelics at the University of Exeter, and Chief Medical Officer of MINDS, with a focus on integrative and relational approaches to healing and consciousness. In this conversation, Dr. Ruffell explores the emerging research on ayahuasca as a treatment for PTSD, drawing on both Western scientific models and Indigenous Shipibo knowledge systems. He outlines how ayahuasca may work through mechanisms such as increased neuroplasticity, disruption of rigid predictive models, and potential epigenetic shifts related to stress and trauma, while emphasizing that these biological explanations exist alongside Indigenous understandings of "cleaning ancestral lines." Sharing preliminary findings from his ongoing research with military veterans in collaboration with Heroic Hearts Project, Dr. Ruffell discusses significant reductions in PTSD symptoms at six-month follow-up, the powerful role of community and ceremony, and the ethical complexities of studying sacred practices through Western scientific tools. He closes with a moving story of a veteran whose healing journey illustrates both the promise and the limits of psychedelic medicine when embedded in relational and cultural context.   In this episode, you'll hear: Western scientific theories for how ayahuasca may alleviate PTSD How trauma-related epigenetic changes may be transmitted across generations Preliminary results from Dr. Ruffell's study of ayahuasca for veterans diagnosed with PTSD The role of community bonding and peer support among veterans in maintaining therapeutic gains Why ayahuasca research in the Amazon includes a broader plant-based healing system—not just the brew itself How Indigenous healers interpret epigenetic findings as confirmation of longstanding ancestral frameworks The ethical considerations of bringing Western measurement tools (like EEG) into sacred ceremonial contexts   Quotes: "This is what I find most interesting about our research—that it is cutting edge science but at the same time, when we conduct it with indigenous healers, we get a whole new perspective on what could be happening when it comes to interpreting the results and also making decisions of what to research as well." [14:09] "According to measures of PTSD on the scales that we're looking at, over 80% of the participants that were scoring for PTSD before their ayahuasca retreats and no longer scoring for PTSD at that six month follow up. So it's not just immediately after the ayahuasca retreats. It's six months later. And that's super, super encouraging." [15:52] "When we take things to the lab, one of the reasons that we might see the effect size diminishing is because we no longer have shamanism, basically, which is exerting a huge effect." [16:55] "Traditionally what would happen is that the curandero would drink ayahuasca and the participants would just be there and the curandero would use the visions that they had with ayahuasca to look into the participants and to diagnose them. And then the healing would come through them singing their medicinal chants, which are the icaros. And then afterwards they would give them a prescription of plants or whatever it is that they needed. And sometimes the prescription would be to drink ayahuasca, but most of the time it wouldn't be. [27:18] "You can't separate like DMT, in my eyes, from the rest of the compounds in ayahuasca, from the ceremony, from the jungle. That, in my opinion, is what makes up Shipibo. Otherwise you just have a bunch of chemicals." [28:20]   Links: Dr. Ruffell's website Dr. Ruffell on LinkedIn Dr. Ruffell on Instagram Onaya website Onaya Science website Onaya on LinkedIn Onaya on Instagram Previous episode: Can Ayahuasca Heal PTSD? with Former Army Ranger Jesse Gould Psychedelic Medicine Association Porangui

On this episode Fred and Gregg welcome Xiaopeng Zhao, PhD, Professor and Chair of Mechanical Engineering at the University of Mississippi, whose research bridges artificial intelligence, robotics, and dementia care. Topics: Dr. Zhao discusses how machine learning techniques are being used to analyze complex EEG brainwave data to detect early-stage Alzheimer's disease, patterns invisible to the human eye but accessible through advanced signal processing. Beyond diagnostics, his lab is deploying humanoid robotic systems to assist individuals with dementia during everyday activities such as making coffee or brushing teeth, aiming to reduce caregiver burden and improve quality of life. The conversation explores “lost moments”, short-term lapses in memory that disrupt daily functioning, and how AI systems might identify and respond to them in real time. Dr. Zhao also addresses usability challenges, patient acceptance, and the importance of human-centered design in deploying assistive technologies. With dementia affecting millions worldwide, this episode examines both the promise and practical realities of integrating AI and robotics into population health strategies. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

According to new Amárach research carried out on behalf of the Department of Enterprise, Tourism and Employment more than four in five businesses (85%) say sustainability is important to the day-to-day running of their business and have considered retrofitting . The findings of the second phase of SME Sustainability Research – Wave 2 were announced by the Minister for Enterprise, Tourism and Employment Peter Burke T.D. and are in line with the previous year's findings. The value of retrofitting The survey of 344 SMEs shows that two in five had taken steps such as insulating their buildings or changing their windows in the past two years to improve their energy efficiency. Speaking at the launch, Minister Burke said by doing so these businesses would also be cutting their energy costs and would become more competitive: "It's really encouraging to see businesses reducing their costs by tackling the energy usage in their buildings. There is however another sizeable cohort of businesses (44%) who cite upfront investment costs as a barrier to becoming more sustainable. "That's why I'd ask SMEs to avail of the Local Enterprise Offices' Energy Efficiency Grant (EEG) and the SEAI's Building Energy Upgrade Scheme (BEUS) to buy energy efficient equipment and to retrofit their buildings. I changed the terms and conditions of the energy efficient grant last year so that a 75% grant is now available, up to a maximum of €10,000, which can make a huge difference to energy bills. In 2025, 681 small business were approved for the EEG at estimated value of €5.7 million, while 186 BEUS grants with an estimated value of €3.36 million were approved." Minister Burke announced the research at Wholesome Kitchen, Dominick St, Mullingar which had recently used the Climate Toolkit 4 Business to understand their environmental impact. Businesses can now also use the Toolkit to measure their Scope 1, 2 and 3 emissions. Minister Burke said by estimating their environmental impact, SMEs can start to tackle it: "Through this research we can see that businesses are also concerned that their staff may not implement sustainability measures. The Toolkit is free so anyone can use it to understand their business's carbon footprint, and it will provide information on where to access the Government's sustainability and energy supports." This year's survey included questions on the potential of the circular economy to Irish businesses. Minister of State for Employment, Small Business & Retail and Circular Economy Alan Dillon T.D. said it's clear that businesses are seeing the enormous value of re-using, recycling and minimising waste: "Not only did more than one in three (35%) respondents say that they already participate in the circular economy, of those that don't, a quarter are interested in doing so. By supporting businesses to reuse resources, reduce waste and keep materials in circulation for longer, they will not only become more sustainable they will cut costs and become more competitive." Key Findings 85% of businesses say sustainability is important to their business on a day-to-day basis, maintaining the high levels recorded in the 2024 research. Businesses said that making a positive difference (35%) and saving money (34%) were the top motivations in becoming sustainable. Just over a quarter of business say that climate change is currently affecting their operations, rising significantly among larger firms and those operating for more than 20 years. Among affected businesses, adverse weather is now the dominant impact, reflecting the growing reality of extreme weather events. Most sustainability action is concentrated in practical, cost-effective areas: waste reduction (49%), energy efficiency (44%), and renewable energy adoption (33%) remain the most common measures adopted by businesses. The main barrier for organisations to act more sustainably remained upfront investment costs (22%), although at a lower rate compared to 2024. This research was under...

Noch vor den Landtagswahlen im März verständigen sich Union und SPD auf neue Eckpunkte zum Gebäudemodernisierungsgesetz. Die Union hat sich dabei weitgehend durchgesetzt: Die Erneuerbarenpflicht von 65 Prozent für neue Heizungen verschwindet aus dem Gesetz, stattdessen kommt eine "Bio-Treppe" und eine Grüngasquote im Gasnetz. Was das konkret bedeutet, wie die ersten Reaktionen ausfallen und was die Neuerungen für den Klimaschutz bedeuten, beleuchten wir in der neuen Folge. Außerdem werfen wir darin einen Blick in einem geleakten Entwurf für das künftige EEG. Vor allem für die Solarwirtschaft enthält dieser erhebliche Unannehmlichkeiten.

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in December 2023. Listen to an episode of the NCS INSIGHTS series focused on meningitis and encephalitis. The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Ceribell. Time is brain when it comes to seizures. Ceribell point-of-care EEG empowers the bedside team to detect or rule out seizure activity in minutes. To learn more, visit ceribell.com. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Jay Gunkelman (500K+ brain scans) and Pete Jansons dig into one of the biggest claims in alpha training — can a week of intensive brain training replace 40 years of Zen practice? Jay explains exactly why that's a mirage, and why brain state and content are not the same thing.From Granger causality and referencing debates to coherence vs. amplitude sequencing, deep brain reorienting for PTSD, and whether neurofeedback can raise IQ — another deep dive with the panel that doesn't gatekeep.

If you're still marketing the old way — guessing what customers want, hoping they'll buy, and watching your competition pull ahead — you're leaving massive money on the table. In today's hyper-competitive world, the winners don't just sell products… they understand the human brain. Amazon didn't become the most valuable company on earth by accident. They mastered the science of influence. Neuromarketing reveals exactly how the brain makes buying decisions — 95% of which happen subconsciously. Instead of relying on surveys or a gut feeling, you measure real brain activity (through eye-tracking, EEG, and fMRI) to trigger instant desire, trust, and action. Amazon lives and breathes this every single day. They don't guess — they know precisely which words, colors, and experiences light up the reward centers in your customers' brains and make them click "Buy Now" without hesitation. maximizeyourinfluece.com

Listen to Full Audio at https://podcasts.apple.com/us/podcast/ai-business-and-development-daily-news-rundown/id1684415169?i=1000751248515

Las ondas delta son el ritmo EEG más lento y de mayor amplitud que se registra en el cerebro. Se definen típicamente en el rango de 0,5 a 4 Hz. Estas oscilaciones aparecen de forma natural durante el sueño profundo de onda lenta[...] ¡Que lo disfrutes! ✅ Si desean sumarse a IVOOX solo tienen que suscribirse o darle el botón del corazoncito ❤️ y comentar : https://www.ivoox.com/podcast-meditaaccion_sq_f1707851_1.html ✅ Si nos sigues en Apple Podcast, ahora nos puedes ayudar a calificar con 5 estrellas ⭐️⭐️⭐️⭐️⭐️. Por favor ayúdanos a llegar a más personas. Tu calificación o Me gusta❤️ no te tomara mas de 10 segundos y ayudará a llegar a más personas. Gracias de antemano!!! Puedes visitarnos en nuestro Sitio Web, para ver el articulo completo: Web: https://meditaaccion.com Síguenos en el canal informativo de Telegram: https://t.me/meditaaccion Síguenos Instagram: https://www.instagram.com/meditaaccion_podcast/ e-Mail: contacto@meditaaccion.com

In this episode Andrea Samadi interviews Thoryn Stevens, CEO and founder of Brain.One, about using AI, wearables, biomarkers and evidence-based micro-habits to create personalized brain-health protocols. Watch our full interview on YouTube here https://www.youtube.com/watch?v=r9UN9kev2CE or listen and follow the show notes here https://andreasamadi.podbean.com/e/can-ai-personalize-your-brain-health-inside-brainones-protocols/  What We Covered on EP 386 with Thoryn Stephens The Problem with Generic Wellness Advice Why most health advice fails to translate into sustained behavior change The gap between research findings and real-world application Why optimization must be systematic, not inspirational From Data to Daily Micro-Habits How Brain.One analyzes peer-reviewed research using AI Turning biometrics (HRV, sleep data, metabolic markers) into actionable protocols Why small, consistent micro-habits compound into long-term neuroplastic change Wearables & What Actually Matters The most misunderstood wearable metrics HRV, sleep architecture, and recovery as early indicators of cognitive health How to avoid becoming obsessive with numbers while still using data intelligently Dementia Prevention & Cognitive Longevity Evidence-based strategies inspired by the Lancet dementia prevention framework Why metabolic health and inflammation play a critical role in brain aging Prevention vs. reversal: when to start optimizing brain health Biological Bottlenecks to Human Potential Stress dysregulation as a performance limiter Sleep architecture and glymphatic clearance Metabolic flexibility and mitochondrial function Why emotional regulation remains foundational to cognitive performance AI in Health: Hype vs. Evidence What makes Brain.One's system evidence-constrained How AI can scale personalized health protocols The future of data-driven behavioral optimization

Fertility care is undergoing a significant shift as new diagnostic technologies offer deeper insight into reproductive health. OTO Fertility focuses on predicting the likelihood of IVF success before treatment begins, giving couples clarity at a stage where uncertainty has traditionally dominated the process. The system uses a wearable device that captures physiological signals and converts them into predictive metrics, offering a noninvasive method for understanding fertility readiness.The challenge addressed by this technology is substantial. IVF remains expensive, time‑consuming, and emotionally demanding, yet the success rate for a single transfer remains low. Many couples undergo multiple cycles without clear guidance on their likelihood of success. By providing predictive insight before treatment, the system aims to reduce unnecessary cycles, lower financial burden, and support more informed decision‑making.Physiological Monitoring and Predictive ModelingThe OTO Fertility device performs medical‑grade ECG and EEG measurements, capturing data from multiple physiological systems. These include cardiac activity, central and autonomic nervous system responses, hormonal regulation patterns, and energy supply indicators. Dozens of body signals are synthesized into a set of metrics that correlate with fertility outcomes. These metrics are then combined into a single index that reflects the couple's overall fertility readiness.Both partners participate in the process, allowing the system to evaluate male and female factors independently and together. This dual‑side approach supports a more complete understanding of fertility challenges, including those that may not be detected through traditional testing. The system also supports natural conception by identifying physiological patterns that can be optimized without clinical intervention.Personalized Guidance Through AIOnce the fertility index is generated, the system provides personalized recommendations designed to improve physiological readiness. These recommendations are based on lifestyle factors that influence fertility, including activity levels, rest, recovery, nutrition, sleep, and stress management. The guidance is tailored to each individual and delivered through the accompanying application, creating a structured pathway for improvement.The use of AI allows the system to adapt recommendations as new data is collected. Daily measurements support continuous monitoring, enabling couples to track progress and understand how their bodies respond to changes. This dynamic approach contrasts with traditional fertility diagnostics, which often rely on static snapshots taken at a single point in time.Broader Fertility Insights and Lifecycle SupportThe technology also provides insight into previously unexplained fertility challenges. A significant portion of infertility cases fall into the unexplained category, where standard tests show no clear cause. By analyzing physiological patterns across multiple systems, the device offers a new layer of understanding that can help clarify these cases.The system extends beyond conception, offering support during pregnancy and postpartum. This continuity allows couples to remain engaged with their physiological health throughout the entire fertility journey. The solution is delivered in partnership with treating physicians and virtual clinics, integrating seamlessly into existing care pathways.ConclusionOTO Fertility introduces a predictive diagnostic system designed to improve IVF outcomes and support natural conception through physiological monitoring and AI‑driven guidance. By providing insight into fertility readiness, offering personalized recommendations, and addressing both partners' health, the system creates a more informed and supportive pathway for couples seeking to build their families. As fertility challenges continue to rise globally, technologies that deliver clarity, personalization, and noninvasive insight are becoming essential components of modern reproductive care.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

Fertility care is undergoing a significant shift as new diagnostic technologies offer deeper insight into reproductive health. OTO Fertility focuses on predicting the likelihood of IVF success before treatment begins, giving couples clarity at a stage where uncertainty has traditionally dominated the process. The system uses a wearable device that captures physiological signals and converts them into predictive metrics, offering a noninvasive method for understanding fertility readiness.The challenge addressed by this technology is substantial. IVF remains expensive, time‑consuming, and emotionally demanding, yet the success rate for a single transfer remains low. Many couples undergo multiple cycles without clear guidance on their likelihood of success. By providing predictive insight before treatment, the system aims to reduce unnecessary cycles, lower financial burden, and support more informed decision‑making.Physiological Monitoring and Predictive ModelingThe OTO Fertility device performs medical‑grade ECG and EEG measurements, capturing data from multiple physiological systems. These include cardiac activity, central and autonomic nervous system responses, hormonal regulation patterns, and energy supply indicators. Dozens of body signals are synthesized into a set of metrics that correlate with fertility outcomes. These metrics are then combined into a single index that reflects the couple's overall fertility readiness.Both partners participate in the process, allowing the system to evaluate male and female factors independently and together. This dual‑side approach supports a more complete understanding of fertility challenges, including those that may not be detected through traditional testing. The system also supports natural conception by identifying physiological patterns that can be optimized without clinical intervention.Personalized Guidance Through AIOnce the fertility index is generated, the system provides personalized recommendations designed to improve physiological readiness. These recommendations are based on lifestyle factors that influence fertility, including activity levels, rest, recovery, nutrition, sleep, and stress management. The guidance is tailored to each individual and delivered through the accompanying application, creating a structured pathway for improvement.The use of AI allows the system to adapt recommendations as new data is collected. Daily measurements support continuous monitoring, enabling couples to track progress and understand how their bodies respond to changes. This dynamic approach contrasts with traditional fertility diagnostics, which often rely on static snapshots taken at a single point in time.Broader Fertility Insights and Lifecycle SupportThe technology also provides insight into previously unexplained fertility challenges. A significant portion of infertility cases fall into the unexplained category, where standard tests show no clear cause. By analyzing physiological patterns across multiple systems, the device offers a new layer of understanding that can help clarify these cases.The system extends beyond conception, offering support during pregnancy and postpartum. This continuity allows couples to remain engaged with their physiological health throughout the entire fertility journey. The solution is delivered in partnership with treating physicians and virtual clinics, integrating seamlessly into existing care pathways.ConclusionOTO Fertility introduces a predictive diagnostic system designed to improve IVF outcomes and support natural conception through physiological monitoring and AI‑driven guidance. By providing insight into fertility readiness, offering personalized recommendations, and addressing both partners' health, the system creates a more informed and supportive pathway for couples seeking to build their families. As fertility challenges continue to rise globally, technologies that deliver clarity, personalization, and noninvasive insight are becoming essential components of modern reproductive care.Interview by Don Baine, The Gadget Professor.Sponsored by: Get $5 to protect your credit card information online with Privacy. Amazon Prime gives you more than just free shipping. Get free music, TV shows, movies, videogames and more. Secure your connection and unlock a faster, safer internet by signing up for PureVPN today.

What makes Lyme disease resolve quickly in some people but turn into a life-altering chronic illness in others? In this episode, world-leading immunologist Dr. Michal “Mikki” Tal, Principal Scientist at MIT, explains what her team is discovering through the MAESTRO Study — the largest clinical research project in MIT's history and the first of its kind to include real Lyme patients in a multi-system biological analysis. Dr. Tal's work sits at the intersection of immunology, bioengineering, and women's health, uncovering how infections like Lyme and COVID can cause persistent inflammation, immune miscommunication, and hormonal imbalance. Through MAESTRO, she's mapping how recovery breaks down — and what can be done to predict, prevent, and ultimately reverse chronic illness.

How do babies learn to navigate diversity in their social worlds? Dr. Hyesung Grace Hwang shares her infant neuroscience (EEG) work showing that early “bias” might be less about emotions (like fear or disklike) and more about attention and information processing. We discuss how the environment, specifically neighborhood diversity shapes infants' brain responses, and the changing cues kids use as they get older to reason about nationality.

Hey, it's Alex, let me catch you up! Since last week, OpenAI convinced OpenClaw founder Peter Steinberger to join them, while keeping OpenClaw.. well... open. Anthropic dropped Sonnet 4.6 which nearly outperforms the previous Opus and is much cheaper, Qwen released 3.5 on Chinese New Year's Eve, while DeepSeek was silent and Elon and XAI folks deployed Grok 4.20 without any benchmarks, and it's 4 500B models in a trenchcoat? Also, Anthropic updated rules state that it's breaking ToS to use their plans for anything except Claude Code & Claude SDK (and then clarified that it's OK? we're not sure) Then Google decided to drop their Gemini 3.1 Pro preview right at the start of our show, and it's very nearly the best LLM folks can use right now (though it didn't pass Nisten's vibe checks) Also, Google released Lyria 3 for music gen (though only 30 seconds?) and our own Ryan Carson blew up on X again with over 1M views for his Code Factory article, Wolfram did a deep dive into Terminal Bench and .. we have a brand new website: https://thursdai.news

Join EEG legend Jay Gunkelman (500,000+ brain scans read) and host Pete Jansons for a deep dive into how montage selection changes what you see in brain maps — and why it matters for clinical accuracy.From LORETA source analysis to the newly validated male vs. female EEG differences, Jay breaks it all down with his signature "bad art" screen shares, landmark UCLA research, and real-world clinical insight.

Molly McVoy, MD, dives into the mental health crisis affecting teens, why anxiety and depression have risen dramatically, and shares breakthrough research using EEG biomarkers and self-management programs that help teens build resilience. Learn more about Daniel Simon, MDLearn more about Molly McVoy, MDNEW! View our Science@UH video podcast on YouTubeLearn more about the University Hospitals Research & Education Institute

If you're a high performer, leader, or founder… chances are your calendar is stacked, your brain is overloaded, and you're trying to ‘push through' like that's the job.Today's guest, Clint Rahe, former Royal Air Force PTI turned executive coach and author of The Cognitive Athleteworks with C-suite leaders who should be in their peak years… but instead are burnt out, exhausted, and running on empty.In this episode, you'll learn how to sustain high performance without paying for it with your health, your focus, or your family.We're breaking down cognitive periodizationhow to create seasons in business how to use micro-recovery to reduce stress between meetings, how to protect deep work, and how to set boundaries that actually stick. Key takeaways-Knowledge workers as cognitive athletes (and why overload kills learning)-Burnout at the top: why leaders hit their “peak years” exhausted-Cognitive periodization: creating “seasons” in business where none exist-Recovery that actually works (micro-breaks, active recovery, energy resets)-The “letdown effect” (why people get sick right after pressure ends)-Energy management vs. time management-Saying no strategically (deep work vs shallow work)-Practical leadership habits: 15-minute daily planning + end-of-day review-Meeting hygiene: 25-min meetings, breaks, and better transitions-Circadian rhythms + scheduling work that fits your energyLinks & resources mentioned-Clint's website: thecognitiveathlete.com.au-Clint on LinkedIn (best place to connect)-Clint's weekly newsletter (Wednesdays)Clint's podcast (short episodes, Mondays)-Book: The Cognitive Athlete (US availability mentioned as Feb 27 on Amazon)-Microsoft Human Factors Lab research mentioned (EEG + breaks between meetings)-Amazon meeting practice referenced (reading memo at start)#GrowthReady #HighPerformance #LeadershipDevelopment #ExecutiveCoach #BurnoutRecovery #ProductivityHacks Send a textSupport the showConnect with Steve Mellor Stay connected and keep growing with Steve: LinkedIn - https://www.linkedin.com/in/steve-mellor-cc/ Instagram - https://www.instagram.com/coachstevemellor Book Steve to speak at your next event → www.stevemellorspeaks.com Support the GrowthReady Podcast by leaving a 5-star rating → Apple Podcasts - https://podcasts.apple.com/us/podcast/growthready-podcast/id1406082163 Connect with GrowthReady Join the community and keep your growth journey going: LinkedIn - https://www.linkedin.com/company/wearegrowthready/ Instagram - https://www.instagram.com/growthreadypodcast/ Facebook - https://www.facebook.com/growthreadywithcoachstevemellor Official Website - https://growthready.com/ ---- This podcast was produced on Riverside and released via ...

We're joined by N. Katherine Hayles, Distinguished Research Professor in English at UCLA, to think through cognition in the broadest and most scaled sense. Hayles is among the foundational thinkers of posthumanism in its Anglophone register, and this conversation tracks her intellectual trajectory from the question of how we became posthuman to her most recent project: an integrated cognitive framework that extends from bacteria to AI. The opening provocation is one she has been developing since large language models appeared as a genuinely literary phenomenon, the claim that LLMs do not speak natural language but produce a computational simulation of it.The umwelt of an LLM (its 'operative world-horizon,' in Uexküll's sense) overlaps with the human umwelt enough for communication to occur, but the divergences are large and consequential. This leads to the question of cognition itself. Against definitions that make consciousness the threshold of cognitive status, Hayles proposes the SIEPAL framework: Sensing, Interpreting, Responding, Anticipating, Learning, under which bacteria, algorithms, and ecosystems all qualify as cognitive. The non-conscious, on this account, isn't pre-cognitive but is in many ways more cognitively capable: faster, closer to environmental noise, less committed to the narratives of coherence that consciousness requires.The final section breaks genuinely new ground with Hayles's turn to analog computation: the argument that digital computation is a historical blip, that biological life has always operated on analog principles, and that the future of computation (neuromorphic chips, organoid computers, hybrid analog-digital architectures) represents not a departure from but a return to what life has always done. She proposes the analog humanities as a corrective to digital humanities, and the computational humanities as the synthesis that might finally close the gap between biological and technological cognition. This one is very much worth enjoying in dialogue with our previous epsiode on the digital.Some references:N. Katherine HaylesHow We Became Posthuman: Virtual Bodies in Cybernetics, Literature, and Informatics, University of Chicago Press, 1999Writing Machines, MIT Press, 2002Unthought: The Power of the Cognitive Nonconscious, University of Chicago Press, 2017Postprint: Books and Becoming Computational, Columbia University Press, 2021Bacteria to AI: Cognition Across Scales (referenced as new/recent book)Leif WeatherbyLanguage Machines: Cultural AI and the End of Remainder Humanism, University of Minnesota Press, 2025Jakob von Uexküll — concept of the Umwelt; the species-specific world-horizon generated through particular sensory and neurological capacitiesWalter FreemanHow Brains Make Up Their Minds, Columbia University Press, 1999 — on EEG waves as the mediating mechanism between individual neurons and global hemispheric activation; the rabbit olfactory system experimentsGregory Bateson — on systems that lose the ability to receive feedback collapsing; referenced without specific title (e.g. Steps to an Ecology of Mind, 1972)Peter Haff — the technosphereStuart Kauffman & Giuseppe Longo, for arguing that biological organisms cannot be mapped into phase space and always follow the adjacent possibleWarren McCulloch & Walter Pitts — the McCulloch-Pitts neuron as a binary model with analog processes underlying the firing thresholdBernd Ulmann — here referenced as an expert on analog computing who argues that continuity vs. discreteness is a secondary rather than primary distinction between analog and digital

What is music actually doing inside of us? In this solo reflection, Jeff Krasno explores the science and soul of how music shapes the human brain, regulates emotion, and connects us across distance and even across difference. Drawing from neuroscience research, Jeff explains how music can synchronize multiple brains at once, aligning nervous systems during shared emotional moments. EEG studies show that powerful passages in music can create real neural convergence, offering a sense of unity beneath belief and identity. He also explores why we are drawn to sad music. Melancholic songs help regulate emotion, releasing soothing and connective chemicals in the brain that allow us to process grief, longing, and distance while feeling less alone.Through stories of live music, memory, and fatherhood, this episode reveals how music: Synchronizes brains and nervous systems Supports emotional processing and regulation Collapses distance through memory and attachment Helps transform sadness into meaning Reminds us of our shared human wiring Music does not ask what we believe. It moves us anyway. This show is made possible by:CBDistillery: Go to CBDistillery.com  and use code COMMUNE for 25% off.Stemregen: Get 20% off your first order at stemregen.co/commune with the code COMMUNEPODBon Charge: Get 15% off when you order at boncharge.com and use promo code COMMUNEVivobarefoot: Try Vivobarefoot risk-free with a 100-day return guarantee, and get 15% off your order at vivobarefoot.com/commune. Timeline: Go to Timeline.com/COMMUNE to claim a special offer for Commune listeners. Sunlighten: Visit sunlighten.com/commune and use code COMMUNE when you fill out the “Get Pricing' form to save up to $1,600 on your purchase.

In this enlightening episode of Unashamed Unafraid, we delve into the challenging yet transformative journey of porn addiction recovery with Dr. Trish Leigh, a cognitive neuroscientist. Dr. Leigh shares her unique approach of using EEG technology to understand and regulate the brain's functioning, helping individuals overcome compulsive sexual behaviors. She discusses the impact of dopamine dependency and the importance of unwiring, rewiring, and hardwiring the brain for long-term recovery. This episode is packed with insights and practical strategies for anyone struggling with or supporting someone through porn addiction recovery.To connect with Dr. Leigh:WEBSITE AND YOUTUBE: https://drtrishleigh.com/ / https://www.youtube.com/@DrTrishLeighFOR BRAIN BASED CONDITIONS: https://www.youtube.com/@SupernormalbyDrTrishLeigh/videosFOR PARTNERS: https://www.youtube.com/@sanityafterbetrayal / https://sanityafterbetrayal.com/INSTAGRAM: https://www.instagram.com/drtrishleigh/BOOK: https://drtrishleigh.com/book/Make a donation and become an Outsider!Follow us on social media! Instagram, Facebook & TikTokSubscribe to our YouTubeCheck out our recommended resourcesWant to rep the message? Shop our MERCH!  For more inspiration, read our blogDo you have a story you are willing to share? Send us an email! contact@unashamedunafraid.com00:00 Introduction to Unashamed Unafraid01:16 Meet Dr. Trish Leigh: Cognitive Neuroscientist02:16 Understanding Porn Addiction and Brain Function03:09 The Recovery Process: Begin, Continue, and End04:16 Using EEG Technology in Recovery08:10 The Impact of Dopamine on Addiction12:17 Unwiring and Rewiring the Brain24:20 Strain Brain vs. Drain Brain26:22 Building a Strong Relationship26:49 The Impact of Porn on Brain Development28:16 Understanding Feedback Loops29:04 Implementing Brain Rewiring Strategies31:16 The Role of Neuroplasticity33:37 The Science Behind Brain Changes35:17 The Importance of Dopamine Regulation39:21 Using Technology for Brain Health42:55 Final Thoughts and Resources

In this powerful and deeply personal episode of the Hinesights Podcast, Kevin Hines sits down with Mariam Khayretdinova, a Harvard alumna, neuroscientist, TEDx speaker, and CEO of Brainify.ai, to explore the future of mental health, suicide prevention, and artificial intelligence.Mariam shares her lived experience with depression and suicidal thoughts beginning at just six years old, growing up in post-Soviet Russia where mental health was heavily stigmatized. Today, she is on a mission to change psychiatry from the inside out by building one of the world's most ambitious brain data platforms.Why is psychiatry still based largely on symptoms and trial-and-error treatment?Why can't we scan the brain to diagnose depression the way we diagnose cancer or heart disease?What role can AI and EEG brain data play in developing precision mental health care?Together, Kevin and Mariam unpack:The reality of suicidal ideation and how isolation increases riskThe importance of “safety measures” and connection during mental health crisesWhy psychiatry is one of medicine's most data-starved fieldsHow artificial intelligence could transform depression treatment and drug developmentThe myths we believe about the brainThe urgent need to treat mental health as brain healthThis episode bridges science and humanity, translating pain into data, suffering into signal, and despair into something we can better understand and respond to with compassion and precision.If you care about mental health innovation, suicide prevention, neuroscience, or the future of AI in medicine, this conversation is essential listening.If you or someone you know is struggling, you are not alone. In the U.S., call or text 988 for the Suicide & Crisis Lifeline. For international resources, please contact your local crisis services.Subscribe to Hinesights for more conversations on resilience, brain health, lived experience, and hope.

In this episode of the Tick Boot Camp Podcast, Matt Sabatello sits down with Yuri Kim, the lead clinical research nurse for MIT's MAESTRO study, described as one of the largest studies in MIT history focused on Lyme disease and Infection-Associated Chronic Illnesses (IACI). Yuri explains how MAESTRO is collecting deep symptom histories and objective measurements—from eye tracking and EEG/P300 auditory testing to NASA Lean dysautonomia testing, capillaroscopy, and multi-sample biological collection—to identify patterns that validate patient experiences and accelerate real-world clinical understanding. Yuri's story is equally compelling: she began as an ER nurse in a Level 1 trauma center, transitioned into research nursing (including neurodegenerative and traumatic brain injury work), moved to South Korea during the pandemic, and ultimately joined MIT after a conversation with Dr. Mikki Tal changed the course of her career. Throughout the conversation, Yuri shares what she's learned from MAESTRO participants: a community often exhausted and dismissed, yet profoundly motivated to help others and drive scientific progress forward. Key Takeaways (Fast Scan) MAESTRO is nearing ~200 participants enrolled, with the chronic Lyme cohort full and enrollment closing soon. The study aims to objectively measure symptoms often dismissed as “anxiety” or “depression,” especially brain fog and dysautonomia. MAESTRO uses multiple cognitive and neurologic measures, including RightEye eye tracking, EEG + P300 auditory “oddball” testing, and remote cognitive battery tests. The team added capillaroscopy (nailfold and toe microvascular imaging) to explore vascular patterns and hemorrhages in chronic illness cohorts. Dysautonomia testing includes NASA Lean Test plus an earpiece device to estimate proxy cerebral blood flow, sometimes showing abnormalities even when vitals look “normal.” Extensive biological sampling (oral, blood, vaginal/rectal) supports proteomics/immune profiling and deeper molecular analysis. Yuri emphasizes: patients' willingness to participate—despite severe symptoms—is the engine of progress and future change. Detailed Chapter-by-Chapter Show Notes 1) Meet Yuri Kim: The Human Side of Cutting-Edge Lyme Research Matt introduces Yuri as the clinical research nurse leading day-to-day operations of MIT's MAESTRO study—positioning her as a rare bridge between lab science, clinicians, and patients. Yuri shares that the study is approaching enrollment completion and that the team is eager to analyze a large dataset to “speak up” for participants who have suffered without clear explanations. Highlights: MAESTRO is one of MIT's largest studies, with enrollment nearing completion. The mission is to transform patient suffering into measurable signals, data, and insight. 2) Yuri's Background: Pharma, ER Nursing, Research, and Why This Work Became Personal Yuri explains her path: early work as a medical information specialist in pharma (including literature searches and clinician guidance, often involving off-label questions), then an intense period as a Level 1 ER nurse where she witnessed both acute crises and chronic illness desperation. Key insight:Yuri notes that in pharma and ER settings, she repeatedly saw the same reality—patients searching for answers, clinicians constrained by time, and chronic illness voices falling through the cracks. 3) From the ER to Neuro Research: Brain Inflammation, TBI, and the Gap in Chronic Illness Care Yuri left ER work largely due to the physical toll of night shifts and moved into academic research at Boston University. She worked on complex studies involving Alzheimer's, amyloidosis, and traumatic brain injury. Matt asks whether Lyme came up in those neuro settings. Yuri says no—but now she views neurodegenerative symptoms differently and believes clinicians should consider underlying root causes, including infection. Listener connection:This segment reinforces how often Lyme-related cognitive decline can be misinterpreted or missed when viewed through siloed specialties. 4) Lyme Awareness Outside the U.S.: South Korea, Tick-Borne Illness, and Global Blind Spots During the pandemic, Yuri relocated to South Korea. She shares that Lyme isn't commonly discussed there, though other tick-borne illnesses exist. Yuri underscores a global concern: agricultural and rural communities face tick exposure without awareness of the chronic implications. 5) How Yuri Joined Dr. Mikki Tal and MAESTRO (And Why She Changed Her Mind) One of the most memorable segments: Yuri reveals she had already accepted another MIT nursing role—but after speaking with Dr. Tal, she pivoted immediately, calling it the best career decision she's ever made. Why it matters: It shows how MAESTRO is not just a study; it's a mission-driven effort that attracts top clinical talent. 6) Day One at MAESTRO: Meeting the Severely Ill and the Community's Unmatched Generosity Yuri recounts a powerful early experience: meeting a participant who was bedbound and profoundly symptomatic, yet eager to contribute anything possible to help the community. Matt connects this to Tick Boot Camp's origin story: people with minimal energy still showed up to help others. The theme becomes clear—Lyme patients are often depleted but relentlessly generous. What MAESTRO Measures (The Four-Hour Visit Breakdown) 7) Brain Fog: Why MAESTRO Treats It as a Complex Phenomenon Yuri explains MAESTRO's approach: brain fog isn't one symptom. It can involve memory, processing speed, visual stimulation sensitivity, pain-triggered cognition changes, and motor response delays. Core idea: MAESTRO attempts to measure brain fog from multiple angles—visual processing, auditory processing, reaction time, and executive function. 8) RightEye Eye Tracking: Visual Stimulus + Reaction Time as Objective Signal Participants complete a structured set of ocular motor tasks (pursuit, saccades) and reaction-time games (shape recognition mapped to numbered inputs). Yuri notes many chronic illness participants struggle even with basic saccades, often aligning with reported visual disturbances. What MAESTRO is measuring: Ocular motor control Visual processing Decision speed Reaction time consistency 9) EEG + P300 “Oddball” Test: Auditory Processing Meets Motor Output Participants wear an EEG cap (19 regions) and listen to tones: common low-pitch and rare high-pitch. They must press the spacebar only for the rare tone. Yuri notes that even a 4-minute test can be exhausting for people with cognitive dysfunction, and participants often describe a frustrating “delay” between knowing what to do and physically doing it. Why this matters: This may help validate cognitive dysfunction even when standard office screening looks normal. 10) Remote Cognitive Battery Testing: Scaling Measurement Beyond MIT Participants complete executive function tests at home (memory, Stroop-like color-word matching, trail-making tasks). Yuri emphasizes why this matters: many patients can't travel, and symptoms vary dramatically by day, cycle, and crash patterns. Big future direction: Remote testing could expand access to bedbound patients and capture “good day vs bad day” variability. 11) Dysautonomia & POTS: NASA Lean Test + Proxy Cerebral Blood Flow Yuri details NASA Lean testing: supine rest, then standing/leaning while monitoring vitals and symptoms. The standout: sometimes vitals appear stable while patients feel intensely symptomatic—yet the cerebral blood flow proxy measurement fluctuates significantly. Clinical implication discussed: This approach could become a tool for identifying dysautonomia-related issues when standard vitals “look fine.” 12) Capillaroscopy: Nailfold + Toe Microvascular Imaging MAESTRO added capillaroscopy to examine microvascular patterns, including abnormal shapes and possible hemorrhages seen more frequently in chronic cohorts (as her clinical observations suggest). They also measure capillaries pre- and post-NASA Lean to explore whether symptomatic shifts correlate with microvascular changes. Why patients find it meaningful: They can visually see something measurable that aligns with how they feel. 13) Standard Neuro Screening Doesn't Capture Lyme Brain Fog Yuri shares a crucial point: participants often perform fine on standard screens like the Mini-Mental State Exam, suggesting that infection-associated cognitive dysfunction can be subtle, dynamic, and not detected by traditional tools—reinforcing the need for MAESTRO-style measurement. Biological Samples: “Measure Everything” (Head to Toe) 14) Multi-Sample Collection: Oral, Blood, Vaginal, Rectal Yuri explains the breadth of biological sampling, including saliva/oral samples (cotton chew + gum swab), multiple blood tubes, and sex-specific sampling to explore immune, hormonal, microbiome, and gynecologic dimensions. Why it's being done: To connect symptom clusters to molecular patterns and explore sex differences in chronic illness response. 15) Storage, Batch Effects, and What Happens After Enrollment Closes Samples are aliquoted and stored at -80°C until they can be processed/shipped in ways that minimize batch effects. The next phase is analysis and collaboration—including proteomics and immune signaling exploration. 16) Giving Back to Participants: The Challenge and the Intention Yuri acknowledges the “fine line” between research-only testing and clinically actionable reporting, but stresses MIT's intention to return what can be responsibly shared through certified partners—while being careful not to over-interpret research findings. Collaboration, Scaling, and What Comes Next 17) Collaboration Across Institutions: The Missing Platform Matt compares Lyme research needs to cybersecurity threat-sharing between banks: competitors collaborate because the threat is bigger than any one organization. Yuri agrees and highlights the need for secure data-sharing platforms—similar to large national efforts in other fields. 18) What's Next: Focus on Female Brain Fog, Hormones, and Remote Studies Yuri previews upcoming directions: Brain fog and hormone cycle relationships Differentiating infection-associated cognitive dysfunction vs menopause-related brain fog Remote/at-home measurement studies to reach more symptomatic and bedbound patients Potential collaborations with pediatric and neuroimmune experts Closing Message: Hope Without Hype Yuri's message to patients and families is simple and emotional: “Please don't give up.” She believes answers are coming because serious teams are working together—and because patients are driving the research forward with their participation.

You're disciplined. You're committed. You show up every day and put in the work. But what happens when effort and motivation aren't delivering the results you know you're capable of? Santiago Brand is an international educator and consultant in brain mapping and neurofeedback who uses real brain data to reveal what's actually happening when people perform, stall, or burn out. Trained as both a sport and clinical psychologist, Santiago has spent over 17 years across more than 26 countries helping leaders and high performers improve focus, recover faster from stress, and perform with greater consistency—not by grinding harder, but by understanding the brain that's running the show. In this conversation, Santiago reveals why even the most driven individuals hit invisible walls. You'll discover how trauma markers and emotional dysregulation show up in brain maps, why high performers resist the truth about their own humanity, and how quantitative EEG technology turns invisible obstacles into something you can finally work with. Because once you see what your brain is doing, you can't unsee it—and that's when real transformation begins. If you've ever felt like you're doing all the right things but the breakthrough still hasn't happened, this episode shows you exactly where to look next.

Convulsive status epilepticus is one of the most morbid neurologic emergencies we manage in the ED, and outcomes depend far more on speed than drug selection. Like ventricular fibrillation, each minute of ongoing convulsions worsens hypoxia, acidosis, cardiovascular instability, and neuronal injury, while making seizures progressively harder to terminate. Modern definitions are intentionally time-compressed to force early, parallel, clock-anchored action. Any patient still convulsing when you reach the bedside should be treated as evolving status epilepticus. In this EM Cases podcast with Dr. Sara Gray, we take a practical, time-based approach to convulsive status epilepticus, focusing on early, adequately dosed benzodiazepines, avoiding common escalation and dosing pitfalls, anticipating post-ictal cardiovascular collapse, and knowing when to escalate to second-line agents, airway control, and anesthetic-dose therapy. We also address the transition to non-convulsive status epilepticus and how to recognize ongoing seizures when EEG is not immediately available. We answer questions such as: Why does time to first benzodiazepine matter more than the drug or route? What critical actions should occur in parallel with the first dose? What are 3 key actions to do in parallel with the first benzodiazepine? Why is underdosing second-line antiseizure medications—especially levetiracetam—a common and dangerous pitfall? When should persistent seizures trigger intubation and anesthetic-dose therapy? How can we identify non-convulsive status epilepticus once tonic-clonic activity stops? And many more (we also include a high yield status epilepticus management algorithm in the show notes!)... If you find EM Cases helpful in your clinical practice, please consider supporting our work so we can continue producing free, high-quality emergency medicine education for clinicians around the world. Make a donation here: https://emergencymedicinecases.com/donation/

if you have any feedback, please send us a text! Thank you!This episode of Vital Times features a conversation with clinician-scientists Dr. Jamie Sleigh and Dr. Elizabeth Whitlock, whose work focuses on delirium and perioperative brain health. They explore the emerging role of intraoperative processed EEG monitoring and its potential to improve postoperative neurological outcomes. This discussion highlights the evolving tools and evidence-based strategies anesthesiologists use to deliver safe, high-quality care and optimize patient outcomes across the perioperative continuum. 

In this episode of The Science of Creativity, Dr. Keith Sawyer interviews cognitive neuroscientist Dr. John Kounios, one of the world's leading researchers on insight, the "aha moment," and the neuroscience of creativity. Kounios—coauthor of The Eureka Factor—has spent decades studying how sudden breakthroughs emerge, what's happening in the brain when insight strikes, and how we can increase the odds of having more creative ideas. Together, Keith and John unpack the mysteries of insight, from Archimedes' bathtub to shower thoughts, jazz improvisation, and why some kinds of creativity flourish only when we're relaxed, a little fuzzy, and not trying too hard. You'll learn what brain areas activate during an aha moment, how EEG and fMRI reveal the timing and location of insight, and why creativity requires both hard analytical work and moments of letting go. This wide-ranging conversation covers the neuroscience of insight, the psychology of mind-wandering, the power of sleep, the secrets of flow states, improvisation, ADHD and creativity, and practical techniques anyone can use to boost creative thinking. In This Episode What the "Eureka effect" really is—and what makes an insight different from everyday thinking Why most people have many small insights they never notice How researchers trigger and measure insights in the lab The brain signature of an aha moment (and why it's like a sudden electrical "pop") Why insight and analytical thinking rely on different brain systems How positive mood, low pressure, and "psychological safety" expand thought Why we get ideas in the shower—and why Thomas Edison napped with steel balls How sleep reorganizes memory and produces breakthrough ideas Why creativity is a "strong spice"—powerful, but only useful at the right moment The surprising connection between ADHD symptoms and insight-based problem solving The neuroscience of flow and why expertise makes effortless creativity possible What jazz improvisation teaches us about creative brain states Practical steps for becoming more creative this week Five Key Takeaways Insight is sudden, non-obvious, and comes with a burst of neural activity. It's a different cognitive process than deliberate problem-solving, and each mode has strengths. Positive mood, reduced pressure, and mind-wandering increase insight. Psychological safety and relaxation widen the scope of thought, allowing remote associations to surface. You can't have insights without preparation. Expertise and hard work load the mind with the building blocks that insights rearrange in new ways. Sleep is one of the most powerful creativity boosters. It consolidates memory, breaks fixation, and often produces solutions you couldn't find the day before. Flow emerges from expertise and reduced frontal-lobe control. In high-skill improvisation (like jazz), creativity becomes automatic, effortless, and deeply absorbing. Practical Advice from John Kounios Get more sleep. It improves mood, reorganizes memory, removes fixation, and dramatically increases insight. Make time for creativity. Insights won't happen if you never give yourself space to think, wander, or play. Music by license from SoundStripe: "Uptown Lovers Instrumental" by AFTERNOONZ "Miss Missy" by AFTERNOONZ "What's the Big Deal" by Ryan Saranich   Copyright (c) 2026 Keith Sawyer

Can consciousness exist independently of the brain? Dr. Marina Weiler, Assistant Professor at the University of Virginia's Division of Perceptual Studies (DOPS), shares research on mediumship, out-of-body experiences, remote viewing, and non-speaking children with psychic abilities. A neuroscientist specializing in consciousness studies, Dr. Weiler explains how rigorous scientific methods are being used to investigate phenomena suggesting the mind operates beyond the physical brain. We discuss the award-winning Bigelow Institute research on Brazilian medium Chico Xavier, who produced over 500 books and 10,000 letters attributed to deceased individuals despite only elementary school education. Dr. Weiler shares current DOPS studies using EEG and eye-tracking technology to investigate out-of-body experiences and telepathy in non-speaking individuals. She describes veridical cases including a three-year-old who accurately reported what his parents were doing while asleep in another room, and addresses the controversy surrounding The Telepathy Tapes podcast. A grounded conversation about consciousness research, afterlife evidence, grief, and what decades of scientific investigation reveals about survival after death. Guest: Dr. Marina Weiler, PhD Assistant Professor of Psychiatry and Neurobehavioral Sciences, Division of Perceptual Studies, University of Virginia Follow DOPS: Website: https://med.virginia.edu/perceptual-studies/ Instagram: @uvadopsYouTube: @uvadivisionofperceptualstu9909 My Books + Offerings: WTF Just Happened?! Book Series Join the Science + Spirituality Circle Host or Attend a Science + Spirituality Salon ⁠⁠⁠⁠⁠⁠⁠Newsletter ⁠⁠⁠ |Patreon | Buy me a coffeeMore at: https://www.wtfjusthappened.net/ Events: Amplify Your Intuition with Karen Bell - Omega Institute virtual event, March 4, 7-9pm EST - Register at eomega.org Full Show Notes

Want to lose your next 3–5 lbs the sustainable way? Join my free 6-day email series where I break down exactly how to structure your workouts, nutrition, and habits if you are a plant-based eater over 50.

Prof Fred Travis is a distinguished neuroscientist and a leading authority on the effects of Transcendental Meditation (TM) on the brain and higher states of consciousness. He serves as Distinguished Professor of Neuroscience, Director of the Center for Brain, Consciousness, and Cognition, and former Dean of the Graduate School at Maharishi University of Management, Iowa, USA, where he has also chaired the Department of Maharishi Vedic Science.Holding a PhD and an MS in Psychology, along with postdoctoral training in sleep research at the UC Davis, Prof Travis's research explores the psychophysiological correlates of meditation, EEG coherence, the development of consciousness, and healthy ageing. His work has demonstrated stable, measurable brain changes associated with transcending practices, effectively bridging modern neuroscience with Vedic psychology and studies of consciousness.He was one of the guest speakers at the 2nd Global Vedic Conference, held at Prasanthi Nilayam from January 23 to 25, 2026.

Join QEEG legend Jay Gunkelman (500,000+ scans) and Dr. Mari Swingle (i-Minds author) with host Pete Jansons for a deep morning dive into EEG patterns, drugs, and brain dynamics.✅ Topic 1: Delta Waves – What They Really MeanDiffuse/global delta: lack of white-matter input, sheet dipoles, parenchymal layersInfra-slow oscillations (less 1 Hz): oxygenation cycles (Yuri Crop), 6 breaths/min resonanceClinical implications: encephalopathy, developmental vs acquired✅ Topic 2: Alpha Blocking & ReactivityBurger effect: eyes-open alpha attenuation ≥50% at O1/O2/PzNon-responsive alpha phenotype = severe disconnect from external worldLow-voltage fast EEG: over-arousal, GABA can slow & reveal alpha✅ Topic 3: Psychedelics & Hallucinogens on EEGDramatic connectivity changes vs medicationsSalvia: gigantic 6–10 s slow waves (600–1000 µV), dissociationRisk: epileptiform activity + DMT/MDMA/psilocybin/ketamine = major contraindicationLow-dose LSD: possible anticonvulsant effect (historical Larry Rouse study)✅ Topic 4: Cannabis (Weed) – Acute vs Chronic EEG EffectsAcute: slows background alpha → helps sleep onsetChronic (Struve work): increases frontal alpha coherence → risk of apathy, depression, affective dysregulation (especially if baseline alpha already high/fast)✅ Bonus NuggetsHRV–EEG overlap: cardio-ballistic artifact, pulse artifact, vagal slowingStatic electricity on hair: minimal issue with proper groundingCarl Pribram memory: holographic storage, traveling waves (John Hughes), personal anecdotesFuture EEG trends: less alcohol → more THC? Shift toward frontal coherence issues

Joining this month's episode of The Scope of Things is Joseph Kim, chief strategy officer of ProofPilot, who talks about his company's first-ever CORE Symposium, where pharma pros shared practical solutions to age-old trial challenges. Kim provides a pragmatic viewpoint on the problematic trio of clinical trials—study execution, recruitment, and engagement—and what change agents are needed to pave the way forward and find an exit from the bottlenecks. Plus, host Deborah Borfitz delivers the latest on a planned mapping of clinical trial deserts, the high cost of accelerated FDA approvals, the best states for cancer research, the world's first in-ear EEG system getting approved, and a new smartphone-based outcome measure for sleep studies.  News Roundup Financial hurdles to trial enrollment Study in the Journal of the National Comprehensive Cancer Network News on the Case Western Reserve University website  Accelerated cancer drug approvals Study in BMJ Medicine Best states for cancer research Blog on SmileHub website In-ear EEG devices Article in Diagnostics World News Ecological momentary assessment in sleep-focused trial Study in JAMA Network Open   Guest Joseph Kim, chief strategy officer for ProofPilot The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider's look at clinical research today.

Et si, demain, votre mot de passe le plus sûr n'était plus votre visage, votre doigt… mais votre cerveau ? Cette idée, qui relevait encore récemment de la science-fiction, est en train de devenir une réalité grâce à un nouveau champ de recherche : l'identification neuronale.L'identification neuronale repose sur un principe simple en apparence : chaque cerveau produit une activité électrique unique. Lorsque nous pensons, regardons une image ou réagissons à un stimulus, des milliards de neurones s'activent selon des schémas spécifiques. Or, ces schémas varient d'un individu à l'autre, un peu comme une signature invisible. L'objectif est donc de transformer cette activité cérébrale en identifiant biométrique.Concrètement, cette technologie utilise des capteurs capables d'enregistrer des signaux cérébraux, souvent via des électroencéphalogrammes, ou EEG. L'utilisateur porte un casque ou un dispositif léger qui capte les ondes émises par son cerveau pendant qu'il effectue une tâche simple : regarder une forme, écouter un son, ou se concentrer sur une image. Ces données sont ensuite analysées par des algorithmes d'intelligence artificielle, qui extraient des caractéristiques stables propres à chaque personne.C'est précisément l'approche développée par la start-up française Yneuro avec son système Neuro ID, présenté comme la première solution d'authentification biométrique fondée sur l'activité cérébrale. L'ambition est claire : proposer une alternative aux méthodes actuelles comme les empreintes digitales, la reconnaissance faciale ou l'iris.Pourquoi chercher à dépasser ces technologies déjà très répandues ? Parce qu'elles ont des failles. Un visage peut être copié à partir d'une photo, une empreinte digitale peut être reproduite, et les bases de données biométriques peuvent être piratées. Le cerveau, lui, est beaucoup plus difficile à imiter. Les signaux neuronaux sont dynamiques, complexes, et quasiment impossibles à deviner sans être physiquement la personne concernée.Autre avantage majeur : l'identification neuronale pourrait permettre une authentification dite « vivante ». Autrement dit, le système ne vérifie pas seulement une caractéristique statique, mais une activité cérébrale en temps réel, ce qui réduit fortement les risques d'usurpation.Pour autant, cette technologie ne rendra pas immédiatement obsolètes les méthodes actuelles. Les capteurs doivent encore être miniaturisés, rendus confortables et peu coûteux. Des questions éthiques majeures se posent aussi : que devient la confidentialité des données cérébrales ? Qui les stocke ? Et dans quel but ?L'identification neuronale ouvre donc une nouvelle ère de la biométrie. Une ère fascinante, prometteuse… mais qui exigera des garde-fous solides. Car pour la première fois, ce n'est plus notre corps que l'on utilise comme clé d'accès, mais l'intimité même de notre activité mentale. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

Psychogenic nonepileptic seizures (PNES) are common, often misunderstood, and increasingly encountered in pediatric emergency care. These events closely resemble epileptic seizures but arise from abnormal brain network functioning rather than epileptiform activity. In this episode of PEM Currents, we review the epidemiology, pathophysiology, and clinical features of PNES in children and adolescents, with a practical focus on Emergency Department recognition, diagnostic strategy, and management. Particular emphasis is placed on seizure semiology, avoiding iatrogenic harm, communicating the diagnosis compassionately, and understanding how early identification and referral to cognitive behavioral therapy can dramatically improve long-term outcomes. Learning Objectives Identify key epidemiologic trends, risk factors, and semiological features that help differentiate psychogenic nonepileptic seizures from epileptic seizures in pediatric patients presenting to the Emergency Department. Apply an evidence-based Emergency Department approach to the evaluation and initial management of suspected PNES, including strategies to avoid unnecessary escalation of care and medication exposure. Demonstrate effective, patient- and family-centered communication techniques for explaining the diagnosis of PNES and facilitating timely referral to appropriate outpatient therapy. References Sawchuk T, Buchhalter J, Senft B. Psychogenic Nonepileptic Seizures in Children-Prospective Validation of a Clinical Care Pathway & Risk Factors for Treatment Outcome. Epilepsy & Behavior. 2020;105:106971. (PMID: 32126506) Fredwall M, Terry D, Enciso L, et al. Outcomes of Children and Adolescents 1 Year After Being Seen in a Multidisciplinary Psychogenic Nonepileptic Seizures Clinic. Epilepsia. 2021;62(10):2528-2538. (PMID: 34339046) Sawchuk T, Buchhalter J. Psychogenic Nonepileptic Seizures in Children - Psychological Presentation, Treatment, and Short-Term Outcomes. Epilepsy & Behavior. 2015;52(Pt A):49-56. (PMID: 26409129) Labudda K, Frauenheim M, Miller I, et al. Outcome of CBT-based Multimodal Psychotherapy in Patients With Psychogenic Nonepileptic Seizures: A Prospective Naturalistic Study. Epilepsy & Behavior. 2020;106:107029. (PMID: 32213454) Transcript This transcript was generated using Descript automated transcription software and has been reviewed and edited for accuracy by the episode's author. Edits were limited to correcting names, titles, medical terminology, and transcription errors. The content reflects the original spoken audio and was not substantively altered. Welcome to PEM Currents: The Pediatric Emergency Medicine Podcast. As always, I'm your host, Brad Sobolewski, and today we are talking about psychogenic non-epileptic seizures, or PNES. Now, this is a diagnosis that often creates a lot of uncertainty in the Emergency Department. These episodes can be very scary for families and caregivers and schools. And if we mishandle the diagnosis, it can lead to unnecessary testing, medication exposure, ICU admissions, and long-term harm. This episode's gonna focus on how to recognize PNES in pediatric patients, how we make the diagnosis, what the evidence says about management and outcomes, and how what we do and what we say in the Emergency Department directly affects patients, families, and prognosis. Psychogenic non-epileptic seizures are paroxysmal events that resemble epileptic seizures but occur without epileptiform EEG activity. They're now best understood as a subtype of functional neurological symptom disorder, specifically functional or dissociative seizures. Historically, these events were commonly referred to as pseudo-seizures, and that term still comes up frequently in the ED, in documentation, and sometimes from families themselves. The problem is that pseudo implies false, fake, or voluntary, and that implication is incorrect and harmful. These episodes are real, involuntary, and distressing, even though they're not epileptic. Preferred terminology includes psychogenic non-epileptic seizures, or PNES, functional seizures, or dissociative seizures. And PNES is not a diagnosis of exclusion, and it does not require identification of psychological trauma or psychiatric disease. The diagnosis is based on positive clinical features, ideally supported by video-EEG, and management begins with clear, compassionate communication. The overall incidence of PNES shows a clear increase over time, particularly from the late 1990s through the mid-2010s. This probably reflects improved recognition and access to diagnostic services, though a true increase in occurrence can't be excluded. Comorbidity with epilepsy is really common and clinically important. Fourteen to forty-six percent of pediatric patients with PNES also have epilepsy, which frequently complicates diagnosis and contributes to diagnostic delay. Teenagers account for the highest proportion of patients with PNES, especially 15- to 19-year-olds. Surprisingly, kids under six are about one fourth of all cases, so it's not just teenagers. We often make the diagnosis of PNES in epilepsy monitoring units. So among children undergoing video-EEG, about 15 to 19 percent may ultimately be diagnosed with PNES. And paroxysmal non-epileptic events in tertiary epilepsy monitoring units account for about 15 percent of all monitored patients. Okay, but what is PNES? Well, it's best understood as a disorder of abnormal brain network functioning. It's not structural disease. The core mechanisms at play include altered attention and expectation, impaired integration of motor control and awareness, and dissociation during events. So the patients are not necessarily aware that this is happening. Psychological and psychosocial features are common but not required for diagnosis and may be less prevalent in pediatric populations as compared with adults. So PNES is a brain-based disorder. It's not conscious behavior, it's not malingering, and it's not under voluntary control. Children and adolescents with PNES have much higher rates of psychiatric comorbidities and psychosocial stressors compared to both healthy controls and children with epilepsy alone. Psychiatric disorders are present in about 40 percent of pediatric PNES patients, both before and after the diagnosis. Anxiety is seen in 58 percent, depression in 31 percent, and ADHD in 35 percent. Compared to kids with epilepsy, the risk of psychiatric disorders in PNES is nearly double. Compared to healthy controls, it is up to eight times higher. And there's a distinct somatopsychiatric profile that strongly predicts diagnosis of PNES. This includes multiple medical complaints, psychiatric symptoms, high anxiety sensitivity, and solitary emotional coping. This profile, if you've got all four of them, carries an odds ratio of 15 for PNES. Comorbid epilepsy occurs in 14 to 23 percent of pediatric PNES cases, and it's associated with intellectual disability and prolonged diagnostic delay. And finally, across all demographic strata, anxiety is the most consistent predictor of PNES. Making the diagnosis is really hard. It really depends on a careful history and detailed analysis of the events. There's no single feature that helps us make the diagnosis. So some of the features of the spells or events that have high specificity for PNES include long duration, so typically greater than three minutes, fluctuating or asynchronous limb movements, pelvic thrusting or side-to-side head movements, ictal eye closure, often with resisted eyelid opening, ictal crying or vocalization, recall of ictal events, and rare association with injury. Younger children often present with unresponsiveness. Adolescents more commonly demonstrate prominent motor symptoms. In pediatric cohorts, we most frequently see rhythmic motor activity in about 27 percent, and complex motor movements and dialeptic events in approximately 18 percent each. Features that argue against PNES include sustained cyanosis with hypoxia, true lateral tongue biting, stereotyped events that are identical each time, clear postictal confusion or lethargy, and obviously epileptic EEG changes during the events themselves. Now there are some additional historical and contextual clues that can help us make the diagnosis as well. If the events occur in the presence of others, if they occur during stressful situations, if there are psychosocial stressors or trauma history, a lack of response to antiepileptic drugs, or the absence of postictal confusion, this may suggest PNES. Lower socioeconomic status, Medicaid insurance, homelessness, and substance use are also associated with PNES risk. While some of these features increase suspicion, again, video-EEG remains the diagnostic gold standard. We do not have video-EEG in the ED. But during monitoring, typical events are ideally captured and epileptiform activity is not seen on the EEG recording. Video-EEG is not feasible for every single diagnosis. You can make a probable PNES diagnosis with a very accurate clinical history, a vivid description of the signs and appearance of the events, and reassuring interictal EEG findings. Normal labs and normal imaging do not make the diagnosis. Psychiatric comorbidities are not required. The diagnosis, again, rests on positive clinical features. If the patient can't be placed on video-EEG in a monitoring unit, and if they have an EEG in between events and it's normal, that can be supportive as well. So what if you have a patient with PNES in the Emergency Department? Step one, stabilize airway, breathing, circulation. Take care of the patient in front of you and keep them safe. Use seizure pads and precautions and keep them from falling off the bed or accidentally injuring themselves. A family member or another team member can help with this. Avoid reflexively escalating. If you are witnessing a PNES event in front of you, and if they're protecting their airway, oxygenating, and hemodynamically stable, avoid repeated benzodiazepines. Avoid intubating them unless clearly indicated, and avoid reflexively loading them with antiseizure medications such as levetiracetam or valproic acid. Take a focused history. You've gotta find out if they have a prior epilepsy diagnosis. Have they had EEGs before? What triggered today's event? Do they have a psychiatric history? Does the patient have school stressors or family conflict? And then is there any recent illness or injury? Only order labs and imaging when clinically indicated. EEG is not widely available in the Emergency Department. We definitely shouldn't say things like, “this isn't a real seizure,” or use outdated terms like pseudo-seizure. Don't say it's all psychological, and please do not imply that the patient is faking. If you see a patient and you think it's PNES, you're smart, you're probably right, but don't promise diagnostic certainty at first presentation. Remember, a sizable proportion of these patients actually do have epilepsy, and referring them to neurology and getting definitive testing can really help clarify the diagnosis. Communication errors, especially early on, worsen outcomes. One of the most difficult things is actually explaining what's going on to families and caregivers. So here's a suggestion. You could say something like: “What your child is experiencing looks like a seizure, but it's not caused by abnormal electrical activity in the brain. Instead, it's what we call a functional seizure, where the brain temporarily loses control of movement and awareness. These episodes are real and involuntary. The good news is that this condition is treatable, especially when we address it early.” The core treatment of PNES is CBT-based psychotherapy, or cognitive behavioral therapy. That's the standard of care. Typical treatment involves 12 to 14 sessions focused on identifying triggers, modifying maladaptive cognitions, and building coping strategies. Almost two thirds of patients achieve full remission with treatment. About a quarter achieve partial remission. Combined improvement rates reach up to 90 percent at 12 months. Additional issues that neurologists, psychologists, and psychiatrists often face include safe tapering of antiseizure medications when epilepsy has been excluded, treatment of comorbid anxiety or depression, coordinating care between neurology and mental health professionals, and providing education for schools on event management. Schools often witness these events and call prehospital professionals who want to keep patients safe. Benzodiazepines are sometimes given, exposing patients to additional risk. This requires health system-level and outpatient collaboration. Overall, early diagnosis and treatment of PNES is critical. Connection to counseling within one month of diagnosis is the strongest predictor of remission. PNES duration longer than 12 months before treatment significantly reduces the likelihood of remission. Video-EEG confirmation alone does not predict positive outcomes. Not every patient needs admission to a video-EEG unit. Quality of communication and speed of treatment, especially CBT-based therapy, matter the most. Overall, the prognosis for most patients with PNES is actually quite favorable. There are sustained reductions in events along with improvements in mental health comorbidities. Quality of life and psychosocial functioning improve, and patients use healthcare services less frequently. So here are some take-home points about psychogenic non-epileptic seizures, or PNES. Pseudo-seizure and similar terms are outdated and misleading. Do not use them. PNES are real, involuntary, brain-based events. Diagnosis relies on positive clinical features, what the events look like and when they happen, not normal lab tests or CT scans. Early recognition and diagnosis, and rapid referral to cognitive behavioral therapy, change patients' lives. If you suspect PNES, get neurology and mental health professionals involved as soon as possible. Alright, that's all I've got for this episode. I hope you found it educational. Having seen these events many times over the years, I recognize how scary they can be for families, schools, and our prehospital colleagues. It's up to us to think in advance about how we're going to talk to patients and families and develop strategies to help children who are suffering from PNES events. If you've got feedback about this episode, send it my way. Likewise, like, rate, and review, as my teenagers would say, and share this episode with a colleague if you think it would be beneficial. For PEM Currents: The Pediatric Emergency Medicine Podcast, this has been Brad Sobolewski. See you next time.

Today, Michael welcomes Dr. James V. Hardt, founder of the BioCybernaut Institute and a pioneer in brainwave feedback for spiritual growth, healing, and performance. For decades James has studied the electrophysiology of advanced meditative states, guiding thousands through seven-day training sessions that convert electroencephalography (EEG) activity into musical tones so people can raise alpha, access theta, and develop coherence. His research links brainwave change with measurable gains in creativity, IQ, anxiety relief, and what he calls true transformation. Conversation Highlights Include: -How the journey began for James as a college physics major who tried early feedback and entered profound non-drug altered states, prompting him to find his life's calling. -Why real-time feedback matters: you immediately know if your practice is deepening or if you're just going through the motions. -What a seven-day training involves—orientation, scalp sensors, mood check-ins, baselines, and listening to layered musical tones that mirror your own brain activity. -How progress is built: begin with alpha for relaxed focus, then layer theta for insight and delta for deep restoration; with continuous feedback, patterns that once took decades of meditation can start to appear in days. -What an "ego attack" can feel like mid-week, and how naming classic hindrances—doubt, drowsiness, distractibility, aversion, boredom, forgetfulness—helps loosen their grip. -Measurable outcomes you can point to: sustained IQ gains and roughly 50% creativity boosts in trained groups compared with no-change controls. -A step-by-step forgiveness practice you can see on electroencephalography: alpha drops when contacting the pain, then rises as compassion and release take hold—often followed by real-world reconnection. -Trainable markers for "angel" and "halo" patterns seen in advanced meditators; why coherence matters and how feedback separates imagination from genuine insight. -James's presentation at the Vatican on his angel brainwave data, his *free ebook,* _The Art of Smart Thinking_, and more! Next, a guided meditation centering on love and gratitude to feel grounded, open-hearted, and present.

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in July 2023.  Listen to the second episode of the NCS INSIGHTS series on status epilepticus (part 2 of 2). The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Ceribell. Time is brain when it comes to seizures. Ceribell point-of-care EEG empowers the bedside team to detect or rule out seizure activity in minutes. To learn more, visit ceribell.com. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Send us a textIn this episode of the WTR Small-Cap Spotlight, host Tim Gerdeman and healthcare analyst Robert Sassoon are joined by Dr. Jim Gilligan, President and Chief Science Officer of Entropy Neurodynamics (ASX: ENP), formerly Tryptamine Therapeutics. Dr. Gilligan explains the motivation behind the company's rebrand and its decision to prioritize three core therapeutic targets: Binge Eating Disorder, Fibromyalgia, and Irritable Bowel Syndrome/abdominal pain. Although Entropy has reported positive Phase 2a results using oral psilocybin across these indications, Dr. Gilligan outlines why the company is shifting its strategy toward developing proprietary IV‑delivered psilocin formulations combined with psychotherapy, beginning with binge eating disorder. The discussion also covers Entropy's work on real‑time EEG and brain entropy as a potential biomarker, the company's financing,  regulatory roadmap, and longer‑term expansion opportunities in areas such as PTSD.

"I have recorded over 500 deaths in my journal... and I can tell you, the room gets crowded when we pass." Join Sandra for a moving interview with Dr. Adam Rizvi, a Critical Care Physician and Neurologist who has spent decades on the frontlines of the ICU. Dr. Rizvi began keeping a "Death Journal" to process the grief of losing patients, and what he discovered changed his view of reality forever. In this episode, Dr. Rizvi shares the unexplainable phenomena he witnesses at the bedside. He tells the incredible story of a dying father whose blood pressure was so low he should have been unconscious, yet he stayed awake and conversing until the exact moment his son walked in the door. He also discusses the medical evidence for the afterlife, sharing cases where patients had zero brain activity yet woke up with clear memories of what happened. This is a powerful conversation about the "Crowded Room" phenomenon, the power of True Forgiveness to heal decades of estrangement, and the visual proof that something leaves the body when we die. In this episode: * The Death Journal: Lessons from witnessing 500+ transitions. * The Impossible Goodbye: How a dying man held on against medical odds for his son. * The "Crowded Room": Why the room feels "standing room only" when someone dies. * Visual Phenomena: Dr. Rizvi describes seeing a ball of light leave a patient's forehead. * Medical Proof: Consciousness exists even when the EEG is flat. * Healing Estrangement: A moving story of a father and daughters reuniting after 30 years. Get Dr. Adam Rizvi's book "Love Does Not Know Death": https://amzn.to/3ZjDPc9 Website: https://lovedoesnotknowdeath.com/ *Connect with Sandra Champlain: * Website (Free book by joining the 'Insiders Club, Free empowering Sunday Gatherings with medium demonstration, Mediumship Classes & more): http://wedontdie.com *Patreon (Early access, PDF of over 800 episodes & more): Visit https://www.patreon.com/wedontdieradio  *Don't miss Sandra's #1 "Best of all things afterlife related" Podcast 'Shades of the Afterlife' at https://shadesoftheafterlife.com

This INSIGHTS episode revisits a core topic from Neurocritical Care ON CALL®, originally released in July 2023.  Listen to the first episode of the NCS INSIGHTS series on status epilepticus (part 1 of 2). The INSIGHTS series is hosted by Casey Albin, MD, and Salia Farrokh, PharmD, and covers topics from Neurocritical Care ON CALL®, the only up-to-date, comprehensive resource dedicated exclusively to the practice of neurocritical care. Learn more about ON CALL®. This episode is sponsored by Ceribell. Time is brain when it comes to seizures. Ceribell point-of-care EEG empowers the bedside team to detect or rule out seizure activity in minutes. To learn more, visit ceribell.com. The NCS Podcast is the official podcast of the Neurocritical Care Society. The views expressed on the NCS Podcast are solely those of the hosts and guests and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice.In this Mind Moments episode, Benjamin Tolchin, MD, MS, FAAN, joins the podcast to provide clinical perspective on the recently published American Academy of Neurology (AAN) guidelines on functional seizures, drawing on his role as a contributing author to the recommendations. Tolchin, Director of the Center for Clinical Ethics at Yale New Haven Health and Associate Professor of Neurology at Yale School of Medicine, discusses what prompted the development of the first AAN guideline in this space and how the evidence base evolved to support formal recommendations. The conversation explores key considerations around diagnosing functional seizures, including history, semiology, EEG use, and the growing role of video documentation. Tolchin also addresses how clinicians should approach psychiatric comorbidities and co-occurring epilepsy, the evidence supporting psychological interventions, why pharmacologic therapies are not recommended for functional seizures themselves, and where major gaps remain in research to advance care in the years ahead.Looking for more Epilepsy discussion? Check out the NeurologyLive® Epilepsy clinical focus page.Episode Breakdown: 1:10 – Why growing evidence prompted the first AAN guideline on functional seizures 3:20 – Diagnostic priorities including history, semiology, EEG, and video documentation 6:15 – Assessing psychiatric comorbidities and co-occurring epilepsy in functional seizures 9:15 – Neurology News Minute 11:30 – Evidence supporting psychotherapy for functional seizures 14:50 – Pharmacological evidence and use of antiseizure medications for functional seizures 18:35 – Barriers to advancing clinical trials in functional seizures 22:05 – Research priorities to refine treatment and long-term outcomes The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Subcutaneous Copper Histidinate as First Treatment for Pediatric Menkes Disease sBLA Acceptance Positions Efgartigimod as Potential First Therapy for Seronegative Myasthenia Gravis High-Dose Nusinersen Gains European Commission Approval for Spinal Muscular Atrophy Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Join tech veteran turned neurotherapist James Croall (Peakmind.health), Jay Gunkelman QEEGD (500,000+ brain scans), Dr. Mari Swingle (i-Minds author), and host Pete Jansons for a deep dive into:

Smith shares EEG-backed results showing how a 5-minute technique called quantum bracketing can resolve emotional trauma and create profound brain changes. #TraumaRelease #QuantumTools #EmotionalHealing

Here's a cheery one for our first episode of the year. Guess what happens when you give several sets of scientists the same dataset and ask them to answer the same question? Well, they all find the same results, right? Right!?Sadly not. This “Many Analysts” problem has been analysed and debated in multiple different scientific fields and across several papers. We cover them in this episode. What does it tell us about the objectivity of science if different teams draw different conclusions from the exact same data?The Science Fictions podcast is brought to you by Works in Progress magazine. Their excellent new article on how we're living in “the golden age of vaccine development”, as discussed on the show, can be found (along with the rest of their articles on science, history, and technology), at worksinprogress.co. We're very grateful that they support the podcast.Show notes* 2015 Nature commentary article on “crowdsourced research” (on racism in football)* And the full 2018 writeup titled “Many Analysts, One Data Set”* Gelman and Loken on the “Garden of Forking Paths”* 2020 many-analysts neuroscience (fMRI) paper* And the plan for the similar study on EEG* 2022 PNAS many-analysts paper on the “hidden universe of uncertainty”* 2026 critique on ideological bias from George Borjas* 2023 critique on effect sizes vs. statistical significance* 2025 ecology & evolution many-analysts paper on blue tits and eucalyptus* 2025 economics many-analysts paper with results on data cleaning* 2024 PNAS critique of many-analysts research* Julia Rohrer's critique of multiverse analysisCreditsThe Science Fictions podcast is produced by Julian Mayers at Yada Yada Productions. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit sciencefictionspod.substack.com/subscribe

We've all heard the dramatic claims about food being “as addictive as drugs,” but a new EEG study offers a much clearer, more grounded look at what's actually happening in the brain.In this episode, host Dr. Kasey Jo Orvidas, breaks down research comparing brain activity in lean adults, adults with obesity, and people with alcohol addiction... and what this reveals about cravings, overeating, and reward.More importantly, we explore how the language we use (addiction, disease, willpower) shapes people's beliefs about change. Because the way we interpret our struggles can either open the door to behavior change… or quietly shut it.Watch full episode on YouTube: https://youtu.be/2jWOfRo8o7gConnect with me on Instagram! Grab 5 Free Lessons in Mindset and Behavior Change Coaching [HMCC WAITLIST]LEAVE A REVIEW, WIN A WORKSHOP! After you leave your review, take a screenshot and upload it to this form to be entered to winWant me to answer your questions on my next Q&A episode? Drop your questions here!Study referenced in this episodeEpisode #19: Is obesity a disease?

Electromagnetic fields (EMF) are everywhere—from our phones to our Wi-Fi to the wiring in our homes. But do they actually disrupt sleep… or is this another modern sleep villain that gets more attention than it deserves? In this episode of Sleep Unplugged, we will:Define what EMF actually is (ELF vs RF, and why “non-ionizing” matters)Learn what research says—and doesn't say—about EMF and the brain, including why subtle EEG changes don't always translate into real-world sleep problemsReview what studies show about EMF and sleep, from brain waves and spindles to subjective sleep qualityFocus on Chuck McGill (Better Call Saul) as a case study, and why his story mirrors what we see in insomnia, hyperarousal, and perceived sleep threatsDetermine if EMF-blocking devices actually work and look at physics vs marketing—and why many products overpromiseList some reasonable precautions without fear, and why chasing the “perfect sleep environment” can sometimes make insomnia worseProduced by: Maeve WinterMore Twitter: @drchriswinter IG: @drchriwinter Threads: @drchriswinter Bluesky: @drchriswinter The Sleep Solution and The Rested Child Thanks for listening and sleep well!

Today, I'm joined by Tim Rosa, CEO of Somnee. Pioneering personalized neurostimulation for sleep, Somnee's clinical-grade headband uses EEG brain mapping to help people get higher quality rest. In this episode, we discuss building the next generation of sleep technology. We also cover: Lessons from scaling Fitbit How EEG-driven neurostimulation works Traction with NBA athletes and elite performers Subscribe to the podcast → insider.fitt.co/podcast   Subscribe to our newsletter → insider.fitt.co/subscribe   Follow us on LinkedIn → linkedin.com/company/fittinsider   Somnee's Website: www.somneesleep.com  Instagram: https://www.instagram.com/somneesleep/  LinkedIn: https://www.linkedin.com/company/somnee/    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co/  Consulting: https://consulting.fitt.co/  Investments: https://capital.fitt.co/   Chapters:  (00:00) Introduction  (01:29) Tim's background (02:13) Scaling Fitbit (03:00) Discovering Somnee  (04:15) Resetting the company (06:00) How Somnee works (07:15) Clinical-grade data (09:00) Sleep onset vs sleep maintenance (11:30) 15-minute sessions vs all-night tracking  (13:45) FDA clearance & clinical validation  (16:00) Go-to-market strategy (18:30) NBA, NFL, and elite athletes  (23:15) The sleep market opportunity (25:30) The future of wearables  (28:00) Device ecosystems and API integrations  (33:00) Series A fundraising (34:45) The 21-session optimization  (36:15) Where to find Somnee and learn more  (37:15) Conclusion  

Full Show Notes: https://bengreenfieldlife.com/lnraw06/ Welcome to RAW—my unfiltered solo podcast (hosted on LIFE Network), where you get the real, behind-the-scenes version of my life: the biohacking experiments I’m running on myself, the protocols I’m building and breaking, the tools and tech I’m stress-testing before anyone hears about them, the ideas in physiology, performance, and longevity I’m diving into, the beliefs I’m questioning, the routines I’m refining, and the unconventional stuff I’m actually doing day to day—no gloss, no script, just a direct line into what I’m thinking, testing, discovering, and living in real time. In this episode, we go deep into the “RAW” terrain of jaw mechanics—think controversial, awkward, and a tad nerdy, but game-changing for health. It all starts at a cocktail party when a Sherlock Holmes-style dentist spots red flags just by looking at his mouth. Cue a year-plus journey into bioesthetic dentistry, mindfully chewing food, and mastering “mewing” (tongue and jaw posture that even changes your face shape). What’s the big actionable win? Stop ignoring your mouth! Rethink your mechanics, posture, and oral hygiene—ditch the fluoride, embrace hydroxyapatite toothpaste, train your tongue to suction to your palate, and breathe through your nose like a pro. Bonus: mouth taping is not just for sleep geeks. Episode Sponsors: Just Thrive: Take the Just Thrive FEEL BETTER challenge today, and save 20% on your first Gut Essentials Bundle. Just Thrive Probiotic is the only probiotic clinically proven to arrive 100% alive in your gut, wrestling in less bloat, better energy, and even clear skin. Digestive Bitters packs 12 science-backed herbs in one tasteless capsule that jumpstarts your digestion and supports GLP-1 production so cravings don’t control you. Visit justthrivehealth.com/BEN and save 20% with promo code BEN. See the difference for yourself or get a full product refund, no questions asked. Fatty15: Fatty15 is on a mission to optimize your C15:0 levels and help you live healthier, longer. You can get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/BEN and using code BEN at checkout. BIOptimizers Magnesium Breakthrough: The 7 essential forms of magnesium included in this full spectrum serving help you relax, unwind, and turn off your active brain after a long and stressful day so you can rest peacefully and wake up feeling refreshed, vibrant, and alert. Go to bioptimizers.com/ben and use code ben15 for 15% off any order. Muse: Muse S Athena combines clinical-grade EEG and fNIRS technology to train your brain in real time while tracking sleep with 86% expert-level accuracy. Get 15% off at choosemuse.com/BENGREENFIELD or use code BENGREENFIELD at checkout. Truvaga: Balance your nervous system naturally with Truvaga's vagus nerve stimulator. Visit Truvaga.com/Greenfield and use code GREENFIELD30 to save $30 off any Truvaga device. Calm your mind, focus better, and recover faster in just two minutes.See omnystudio.com/listener for privacy information.

Full Shownotes: https://bengreenfieldlife.com/podcast/495/ In this episode, I take you through a solo Q&A exploring topics like the best sauna practices, the real benefits of walking 7,000 steps a day, and the latest research on gut health treatments—including my personal experience starting a fecal microbiota transplant for chronic issues. How perceived food sensitivities can sometimes create real symptoms, clear up concerns about ketone supplements and liver health, and emphasize the importance of staying active throughout the day. I also mention my biohacking binder and let you know all the resources, studies, and tools I recommend will be linked in the show notes for anyone wanting more details. You’ll gain access to my complete binder of home biohacking tools and gadgets designed to support long-term health and performance (click here to start exploring). Episode Sponsors: IM8: Ditch the cabinet full of supplements—IM8 packs 92 powerhouse ingredients into one delicious scoop for all-day energy, gut health, and cellular support. Go to IM8Health.com and use code BEN for an exclusive gift—fuel your body the right way! Quantum Upgrade: Recent research has revealed that the Quantum Upgrade was able to increase ATP production by a jaw-dropping 20–25% in human cells. Unlock a 15-day free trial with the code BEN15 at quantumupgrade.io. Muse: Muse S Athena combines clinical-grade EEG and fNIRS technology to train your brain in real time while tracking sleep with 86% expert-level accuracy. Get 15% off at choosemuse.com/BENGREENFIELD or use code BENGREENFIELD at checkout. BIOptimizers Magnesium Breakthrough: The 7 essential forms of magnesium included in this full-spectrum serving help you relax, unwind, and turn off your active brain after a long and stressful day, so you can rest peacefully and wake up feeling refreshed, vibrant, and alert. Go to bioptimizers.com/ben and use code ben15 for 15% off any order. LMNT: Everyone needs electrolytes, especially those on low-carb diets, who practice intermittent or extended fasting, are physically active, or sweat a lot. Go to DrinkLMNT.com/BenGreenfield to get a free sample pack with your purchase!See omnystudio.com/listener for privacy information.

Full Show Notes: BenGreenfieldLife.com/nicknorwitz In this episode with Dr. Nick Norwitz, you’ll get to discover how a Harvard-trained MD/PhD used a simple, eyebrow-raising experiment with Oreos to challenge conventional thinking on cholesterol, metabolism, and the stories told about health. We dive into his now-viral “Oreo experiment,” where adding Oreos to a ketogenic diet dropped his LDL cholesterol faster and more effectively than a high-intensity statin—an unexpected outcome that opens the door to deeper questions about lipid markers, risk factors, and how the body actually processes dietary fats. Nick Norwitz MD PhD is a researcher-educator whose mission is to “Make Metabolic Health Mainstream.” He graduated Valedictorian from Dartmouth College, majoring in Cell Biology and Biochemistry, before completing his PhD in Metabolism at the University of Oxford and his MD at Harvard Medical School. Nick has made a name for himself as a clinical research and metabolic health educator, speaking and writing on topics ranging from brain health, the microbiome, mental health, muscle physiology, mitochondrial function, cholesterol and lipids, and so on. Episode Sponsors: CAROL Bike: The science is clear—CAROL Bike is your ticket to a healthier, more vibrant life. And for a limited time, you can get $100 off yours with the code BEN. Don't wait any longer, join over 25,000 riders and visit carolbike.com/ben today. LVLUP Health: I trust and recommend LVLUP Health for your peptide needs as they third-party test every single batch of their peptides to ensure you’re getting exactly what you pay for and the results you’re after! Head over to lvluphealth.com/BGL and use code BEN15 for a special discount on their game-changing range of products. Muse: Muse S Athena combines clinical-grade EEG and fNIRS technology to train your brain in real time while tracking sleep with 86% expert-level accuracy. Get 15% off at choosemuse.com/BENGREENFIELD or use code BENGREENFIELD at checkout. LeelaQ: Not only do LeelaQ’s products neutralize EMFs, increase ATP production, optimize HRV, and improve blood flow, but they've been third-party proven to do so in placebo-controlled double-blind studies. Visit leelaq.com and use code BEN10 for 10% off. BlockBlueLight: BlockBlueLight BioLights are the only lights extensively tested and recommended by building biologist Brian Hoyer as truly flicker-free, ultra-low EMF, and circadian-friendly, with three modes (day, evening, night) that support natural rhythms and optimize sleep quality. Get 10% off your first order at blockbluelight.com/Ben (discount autoapplied at checkout).See omnystudio.com/listener for privacy information.